[Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis].
A review of immunosuppressive therapy of dermatoses is given. The pathogenesis of autoimmun diseases is discussed. The treatment of autoimmun diseases and of psoriasis with immunosuppressive drugs is ilucidated.
D001327:Autoimmune Diseases / Q000188:drug therapy*; D003874:Dermatitis Herpetiformis / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D010392:Pemphigus / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy*; D011711:Pyoderma / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D008727:Methotrexate
Immunosuppressiva zur Behandlung von Autoimmunkrankheiten der Haut und der Psoriasis